These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 29653494)

  • 1. Renal nerve stimulation identifies aorticorenal innervation and prevents inadvertent ablation of vagal nerves during renal denervation.
    de Jong MR; Hoogerwaard AF; Adiyaman A; Smit JJJ; Heeg JE; van Hasselt BAAM; Misier ARR; Elvan A
    Blood Press; 2018 Oct; 27(5):271-279. PubMed ID: 29653494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased Sympathetic Renal Innervation in Hemodialysis Patients Is the Anatomical Substrate of Sympathetic Hyperactivity in End-Stage Renal Disease.
    Mauriello A; Rovella V; Anemona L; Servadei F; Giannini E; Bove P; Anselmo A; Melino G; Di Daniele N
    J Am Heart Assoc; 2015 Nov; 4(12):. PubMed ID: 26611731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ConfidenHT™ System for Diagnostic Mapping of Renal Nerves.
    Tsioufis C; Dimitriadis K; Tsioufis P; Patras R; Papadoliopoulou M; Petropoulou Z; Konstantinidis D; Tousoulis D
    Curr Hypertens Rep; 2018 May; 20(6):49. PubMed ID: 29779124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective vs. Global Renal Denervation: a Case for Less Is More.
    Fudim M; Sobotka AA; Yin YH; Wang JW; Levin H; Esler M; Wang J; Sobotka PA
    Curr Hypertens Rep; 2018 May; 20(5):37. PubMed ID: 29717380
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of renal nerve stimulation in percutaneous renal denervation for hypertension: A mini-review.
    Huang HC; Cheng HM; Chia YC; Li Y; Van Minh H; Siddique S; Sukonthasarn A; Tay JC; Turana Y; Verma N; Kario K; Wang TD
    J Clin Hypertens (Greenwich); 2022 Sep; 24(9):1187-1193. PubMed ID: 36196464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renal denervation in the management of hypertension in adults. A clinical consensus statement of the ESC Council on Hypertension and the European Association of Percutaneous Cardiovascular Interventions (EAPCI).
    Barbato E; Azizi M; Schmieder RE; Lauder L; Böhm M; Brouwers S; Bruno RM; Dudek D; Kahan T; Kandzari DE; Lüscher TF; Parati G; Pathak A; Ribichini FL; Schlaich MP; Sharp ASP; Sudano I; Volpe M; Tsioufis C; Wijns W; Mahfoud F
    EuroIntervention; 2023 Mar; 18(15):1227-1243. PubMed ID: 36789560
    [TBL] [Abstract][Full Text] [Related]  

  • 7. European Society of Hypertension position paper on renal denervation 2021.
    Schmieder RE; Mahfoud F; Mancia G; Azizi M; Böhm M; Dimitriadis K; Kario K; Kroon AA; D Lobo M; Ott C; Pathak A; Persu A; Scalise F; Schlaich M; Kreutz R; Tsioufis C;
    J Hypertens; 2021 Sep; 39(9):1733-1741. PubMed ID: 34261957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of catheter-based renal denervation in the absence of antihypertensive medications (SPYRAL HTN-OFF MED Pivotal): a multicentre, randomised, sham-controlled trial.
    Böhm M; Kario K; Kandzari DE; Mahfoud F; Weber MA; Schmieder RE; Tsioufis K; Pocock S; Konstantinidis D; Choi JW; East C; Lee DP; Ma A; Ewen S; Cohen DL; Wilensky R; Devireddy CM; Lea J; Schmid A; Weil J; Agdirlioglu T; Reedus D; Jefferson BK; Reyes D; D'Souza R; Sharp ASP; Sharif F; Fahy M; DeBruin V; Cohen SA; Brar S; Townsend RR;
    Lancet; 2020 May; 395(10234):1444-1451. PubMed ID: 32234534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 2019 Consensus Statement of the Taiwan Hypertension Society and the Taiwan Society of Cardiology on Renal Denervation for the Management of Arterial Hypertension.
    Wang TD; Lee YH; Chang SS; Tung YC; Yeh CF; Lin YH; Pan CT; Hsu CY; Huang CY; Wu CK; Sung PH; Chiang LT; Wang YC; Tsai WC; Lin TT; Lin CP; Chen WJ; Hwang JJ
    Acta Cardiol Sin; 2019 May; 35(3):199-230. PubMed ID: 31249454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current problems in renal denervation and a hope to break the stage.
    Hu X; Zhou H; Chen W; Li D; Du H; Xia T; Yin Y
    Hypertens Res; 2023 Dec; 46(12):2654-2660. PubMed ID: 37500716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and efficacy of renal sympathetic denervation: a 9-year long-term follow-up of 24-hour ambulatory blood pressure measurements.
    Vogt A; Dutzmann J; Nußbaum M; Hoyer D; Tongers J; Schlitt A; Sedding D; Plehn A
    Front Cardiovasc Med; 2023; 10():1210801. PubMed ID: 37404730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emerging topics on renal denervation in hypertension: anatomical and functional aspects of renal nerves.
    Katsurada K; Kario K
    Hypertens Res; 2023 Jun; 46(6):1462-1470. PubMed ID: 36991064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patient-Level Pooled Analysis of Ultrasound Renal Denervation in the Sham-Controlled RADIANCE II, RADIANCE-HTN SOLO, and RADIANCE-HTN TRIO Trials.
    Kirtane AJ; Sharp ASP; Mahfoud F; Fisher NDL; Schmieder RE; Daemen J; Lobo MD; Lurz P; Basile J; Bloch MJ; Weber MA; Saxena M; Wang Y; Sanghvi K; Jenkins JS; Devireddy C; Rader F; Gosse P; Sapoval M; Barman NC; Claude L; Augustin D; Thackeray L; Mullin CM; Azizi M;
    JAMA Cardiol; 2023 May; 8(5):464-473. PubMed ID: 36853627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal Sympathetic Denervation for Hypertension.
    Guber K; Kirtane AJ
    Kidney Int Rep; 2022 Oct; 7(10):2129-2140. PubMed ID: 36217529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rationale and Design of Sympathetic Mapping/Ablation of Renal Nerves Trial (SMART) for the Treatment of Hypertension: a Prospective, Multicenter, Single-Blind, Randomized and Sham Procedure-Controlled Study.
    Wang J; Sun N; Ge J; Jiang H; Yin Y; Chen M; Wang Y; Yao C; Yan X; Sobotka PA; Huo Y
    J Cardiovasc Transl Res; 2023 Apr; 16(2):358-370. PubMed ID: 36042146
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The position of renal denervation in treatment of hypertension: an expert consensus statement.
    Zeijen VJM; Kroon AA; van den Born BH; Blankestijn PJ; Meijvis SCA; Nap A; Lipsic E; Elvan A; Versmissen J; van Geuns RJ; Voskuil M; Tonino PAL; Spiering W; Deinum J; Daemen J
    Neth Heart J; 2023 Jan; 31(1):3-11. PubMed ID: 36001280
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Present Evidence of Determinants to Predict the Efficacy of Renal Denervation.
    Zhou H; Xu Y; Chen W; Wang L; Du H; Liu H; Ling Z; Yin Y
    Int J Hypertens; 2022; 2022():5694127. PubMed ID: 35992203
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term efficacy and safety of renal denervation in the presence of antihypertensive drugs (SPYRAL HTN-ON MED): a randomised, sham-controlled trial.
    Mahfoud F; Kandzari DE; Kario K; Townsend RR; Weber MA; Schmieder RE; Tsioufis K; Pocock S; Dimitriadis K; Choi JW; East C; D'Souza R; Sharp ASP; Ewen S; Walton A; Hopper I; Brar S; McKenna P; Fahy M; Böhm M
    Lancet; 2022 Apr; 399(10333):1401-1410. PubMed ID: 35390320
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.